NASDAQ:GERN
$3.60
(
6.51%
)
Friday, 2nd Jun 2023
Geron Corporation Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $2.50 | $3.66 | Friday, 2nd Jun 2023 GERN stock ended at $3.60. This is 6.51% more than the trading day before Thursday, 1st Jun 2023. During the day the stock fluctuated 8.28% from a day low at $3.38 to a day high of $3.66. |
| 90 days | $1.95 | $3.66 | |
| 52 weeks | $1.18 | $3.84 |
Historical Geron Corporation prices
| Date | Open | High | Low | Close | Volume |
| 2023-06-02 | $3.45 | $3.66 | $3.38 | $3.60 | 16 792 307 |
| 2023-06-01 | $3.30 | $3.43 | $3.24 | $3.38 | 4 115 013 |
| 2023-05-31 | $3.34 | $3.41 | $3.22 | $3.27 | 6 457 205 |
| 2023-05-30 | $3.28 | $3.37 | $3.25 | $3.32 | 5 365 464 |
| 2023-05-26 | $3.25 | $3.53 | $3.21 | $3.25 | 13 680 761 |
| 2023-05-25 | $3.15 | $3.17 | $3.05 | $3.13 | 4 675 791 |
| 2023-05-24 | $3.04 | $3.16 | $3.00 | $3.14 | 5 502 939 |
| 2023-05-23 | $3.16 | $3.23 | $3.02 | $3.07 | 6 277 514 |
| 2023-05-22 | $3.10 | $3.18 | $3.09 | $3.15 | 6 208 063 |
| 2023-05-19 | $3.02 | $3.09 | $2.98 | $3.08 | 5 682 158 |
| 2023-05-18 | $3.02 | $3.04 | $2.94 | $2.98 | 4 722 495 |
| 2023-05-17 | $2.99 | $3.04 | $2.93 | $3.02 | 5 119 325 |
| 2023-05-16 | $2.99 | $3.06 | $2.94 | $2.99 | 4 353 582 |
| 2023-05-15 | $3.12 | $3.15 | $2.99 | $3.04 | 5 519 547 |
| 2023-05-12 | $2.95 | $3.12 | $2.89 | $3.10 | 9 972 277 |
| 2023-05-11 | $2.84 | $3.01 | $2.77 | $2.89 | 7 093 930 |
| 2023-05-10 | $2.83 | $2.84 | $2.73 | $2.82 | 4 051 735 |
| 2023-05-09 | $2.73 | $2.82 | $2.73 | $2.81 | 5 110 790 |
| 2023-05-08 | $2.77 | $2.81 | $2.71 | $2.75 | 3 882 441 |
| 2023-05-05 | $2.74 | $2.81 | $2.69 | $2.76 | 3 863 778 |
| 2023-05-04 | $2.68 | $2.75 | $2.64 | $2.70 | 4 496 022 |
| 2023-05-03 | $2.53 | $2.70 | $2.50 | $2.67 | 5 250 914 |
| 2023-05-02 | $2.52 | $2.56 | $2.46 | $2.48 | 4 702 774 |
| 2023-05-01 | $2.46 | $2.57 | $2.45 | $2.56 | 3 892 328 |
| 2023-04-28 | $2.38 | $2.48 | $2.35 | $2.46 | 3 404 059 |
| 2023-04-27 | $2.43 | $2.43 | $2.33 | $2.38 | 3 405 132 |
| 2023-04-26 | $2.39 | $2.45 | $2.36 | $2.43 | 3 785 568 |
| 2023-04-25 | $2.65 | $2.66 | $2.39 | $2.42 | 4 225 073 |
| 2023-04-24 | $2.69 | $2.71 | $2.51 | $2.65 | 7 549 302 |
| 2023-04-21 | $2.58 | $2.69 | $2.46 | $2.67 | 6 519 890 |
| 2023-04-20 | $2.45 | $2.61 | $2.35 | $2.51 | 13 743 682 |
| 2023-04-19 | $2.06 | $2.52 | $2.06 | $2.49 | 19 986 406 |
| 2023-04-18 | $2.08 | $2.10 | $2.04 | $2.08 | 2 419 208 |
| 2023-04-17 | $1.97 | $2.06 | $1.97 | $2.05 | 5 120 536 |
| 2023-04-14 | $2.04 | $2.04 | $1.95 | $1.97 | 3 416 267 |
| 2023-04-13 | $2.00 | $2.08 | $1.97 | $2.04 | 5 941 496 |
| 2023-04-12 | $2.01 | $2.04 | $1.96 | $1.97 | 4 200 924 |
| 2023-04-11 | $2.02 | $2.06 | $1.99 | $2.01 | 5 325 350 |
| 2023-04-10 | $2.03 | $2.08 | $1.99 | $2.02 | 3 260 154 |
| 2023-04-06 | $2.00 | $2.09 | $1.97 | $2.05 | 5 283 655 |
| 2023-04-05 | $2.07 | $2.08 | $1.96 | $2.00 | 6 075 294 |
| 2023-04-04 | $2.16 | $2.17 | $1.99 | $2.07 | 8 694 731 |
| 2023-04-03 | $2.14 | $2.21 | $2.12 | $2.17 | 4 811 370 |
| 2023-03-31 | $2.18 | $2.21 | $2.13 | $2.17 | 4 722 166 |
| 2023-03-30 | $2.25 | $2.26 | $2.12 | $2.14 | 4 112 694 |
| 2023-03-29 | $2.20 | $2.25 | $2.15 | $2.23 | 5 140 711 |
| 2023-03-28 | $2.31 | $2.36 | $2.16 | $2.17 | 4 127 407 |
| 2023-03-27 | $2.33 | $2.38 | $2.30 | $2.34 | 3 835 982 |
| 2023-03-24 | $2.30 | $2.35 | $2.24 | $2.33 | 3 716 835 |
| 2023-03-23 | $2.31 | $2.35 | $2.20 | $2.28 | 4 538 383 |
About Geron Corporation
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes a... GERN Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
